Garantie de satisfaction à 100% Disponible immédiatement après paiement En ligne et en PDF Tu n'es attaché à rien
logo-home
NURS 6565 FNP Review-AANP $15.49
Ajouter au panier

Examen

NURS 6565 FNP Review-AANP

 0 fois vendu
  • Cours
  • Établissement

NURS 6565 FNP Review-AANP, Walden University

Aperçu 4 sur 94  pages

  • 8 septembre 2023
  • 94
  • 2023/2024
  • Examen
  • Questions et réponses
avatar-seller
NURS 6565 FNP Review - AANP

, PREVENTION/HEALTH PROMOTION/IMMUNIZATION


LEVEL OF PREVENTION IMMUNIZATION PEARLS SMOKING - PACK YEAR HX
➢ PRIMARY HX of Anaphylactic Immunization to avoid Number of packs-per-day (PPD)
o Goal: preventing the health problem, the reaction Multiplied by # of years smoked
most cost-effective form of healthcare Neomycin IPV, MMR, varicella
o Example: immunizations, counseling about Streptomycin, IPV, smallpox
safety, injury and disease prevention polymyxin B, neomycin 5 A’S OF SMOKING CESSATION
➢ SECONDARY Baker’s yeast Hepatitis B 1. Ask about tobacco use
o Goal: detecting disease in early, Gelatin, neomycin Varicella zoster
2. Advise to quit
asymptomatic, or preclinical state to minimize Gelatin MMR
3. Assess willingness to make a quit
its impact
o Example: screening tests, such as BP check, Previously unvaccinated adults age 19-59 with attempt
mammography, colonoscopy, ASA in hx MI diabetes should be vaccinated against Hepatitis B 4. Assist in quit attempt
➢ TERTIARY LIVE VACCINES 5. Arrange follow-up
o Goal: minimizing negative disease induced o MMR
outcomes ▪ Patients born before 1957 have
o Example: in established disease, adjusting likelihood of immunity due to PNEUMOCOCCAL IMMUNIZATION
therapy to avoid further target organ damage. natural infection
➢ PCV13 associated with greater
Potentially viewed as a failure of primary ▪ Two doses 1 month apart for
prevention, support groups those never immunized immunogenicity
o Varicella ➢ PPSV23 not licensed for children
o Zostavax under 2
IMMUNIZATION PRINCIPLES o Intranasal Flu Mist ➢ Indications: chronic lung disease,
➢ Community (herd immunity) ➢ Avoid these with Pregnancy, immune suppression chronic cardiovascular disease,
o Immunize those who can be to protect those and with HIV (CD4 count < 200) – case by case diabetes, chronic liver disease,
who cannot be immunized situation
chronic alcohol abuse, smokers,
➢ Active immunity ➢ Rotavirus
o Avoid with SCID (severe combined malignancy, chronic renal failure,
o Resistance developed in response to an
immunodeficiency) asplenia, sickle cell,
antigen (either infection or vaccine)
immunocompromised, HIV.
➢ Passive immunity
o Immunity conferred by an antibody produced HEPATITIS B ➢ PCV13 followed by PPSV23 one year
in another host (infant of mother or immune ➢ Chronic Hep B can lead to hepatocellular later and then again at 65
globulin carcinoma, cirrhosis and continued infectivity o Exception: HIV (8 weeks
later)
➢ Childhood Hep B vaccines began in 1982
Immunize unless sending to the hospital in an ambulance
➢ 3 dose series 0, 1, 6 months ➢ If PPSV23 before age 65, repeat in 5
➢ If not vaccinated and exposed – HBIG and series years
➢ If vaccinated and exposed – single dose vaccine

, PREVENTION/HEALTH PROMOTION/IMMUNIZATION
TETANUS
VARICELLA ➢ Infection caused by Clostridium
SMALLPOX
➢ Live virus; 2 dose series starting > 1 year of age tetani – found in soil lead to lockjaw
➢ Caused by variola virus
➢ Although highly protective, mild cases of chicken ➢ If no previous immunity - give Tdap
➢ Infective droplets – contagious during fever, but
pox have been associated with the disease followed by Td in 1 and 6 months
most contagious during rash
➢ Varicella antibody titers should be ordered on a ➢ Need vaccine every 10 years with a
o Contagious until last scab falls off
healthcare worker who had chicken pox as a child single dose of Tdap in adulthood
➢ Stopped vaccinating in 1972
➢ Varicella Zoster Immune Globulin (VZIG) is made ➢ If dirty wound – BOOST if not TD in
➢ Incubation period 7-17 days
of pooled blood product with excellent safety 5 years (Tdap and Immunoglobin if
➢ Prodromal stage – fever, malaise, headaches,
rating (given if contraindications for vaccine) no previous vaccine)
body aches
➢ Pregnant women without immunity should be
➢ Rash starts on face > arms/legs > hands/feet
vaccinated with two doses after giving birth
o All lesions within same phase and spreads HEPATITIS A
➢ Varicella is transmitted via droplet
within 24 hours ➢ Peak infectivity occurs the 2-week
➢ Vaccination within 3-5 days of exposure has
➢ Vaccination within 3 days of exposure reduces period before the onset of jaundice
shown benefits to reduce disease
severity or elevated liver enzymes
➢ Vaccinia – unique immunization method ➢ Approximately 50% of cases have
o 2-pronged needle dipped into vaccine and no specific risk factors identified
then pricks skin STAGES OF CHANGE MODEL
➢ PRECONTEMPLATION ➢ When traveling to developing
o Not interested or minimalizes nations, avoid foods that are eaten
➢ CONTEMPLATION raw
POLIOVIRUS
o Considering change, looks at positive and ➢ Administer 4-6 weeks prior to
➢ Transmission is fecal-oral
negative, feels “stuck” traveling to an area where disease is
➢ PREPARATION endemic
SENSITIVITY AND SPECIFICITY o Exhibits some change behaviors, but does ➢ Treatment is supportive
➢ Sensitivity – ability of a test to detect a person not have tools to proceed
who has disease (SEN rule in) ➢ ACTION SHINGLES VACCINE
➢ Specificity – ability of a test to detect a person o Ready to go forward, takes concrete ➢ Recommended for everyone except
who is healthy (SPOUT – rule out) steps, but no consistency those contraindicated
➢ MAINTENANCE/RELAPSE ➢ Infectious until lesions dry/crusted
o Learns to continue the change and ➢ Zostavax
embraced the healthy habit o Live; One-time dose age 60
➢ Shingrix
o Non-live; 2 doses age 50
o Preferred vaccine

, PREVENTION/HEALTH PROMOTION/IMMUNIZATION

➢ Prostate Cancer
US PREVENTATIVE SERVICES TASK FORCE CANCER PREVALENCE
o Benefits of PSA screening do not
➢ Aspirin use to prevent cardiovascular disease and ➢ Skin cancer is most common cancer
outweigh the disadvantages
colorectal cancer o Basal cell carcinoma
o Risk factors:
o Age 50-59 with >10% ASCVD o Melanoma highest mortality
▪ Age > 50
➢ Breast Cancer ➢ Men – prostate cancer
▪ African ancestry
o Mammography age 50-74 (every 2 years) ➢ Women – breast cancer
▪ First degree relative
o Risk factors (start age 40 or BRCA1/2) ➢ Gynecological
➢ Ovarian Cancer
▪ Previous hx of breast cancer o Uterine/endometrial
o Routine screening not recommended
▪ >2 first-degree relatives o Ovarian
o BRCA1/BRCA2 mutations – refer to
▪ Early menarche, late menopause, ➢ Children – acute lymphoblastic
specialist
nulliparity leukemia (ALL)
➢ Skin Cancer Counseling
▪ obesity
o Recommend for those with fair skin
➢ Cervical Cancer
➢ Abdominal Aortic Aneurysm
o Age 21 – screen every 3 years
o Men age 65-75 who have smoked
o Age 30 – screen with HPV every 5 years
o One-time ultrasound MORTALITY
o Hysterectomy with removal of cervix –
➢ Lipid Disorders ➢ Leading cause of death (all ages)
only need screening if hysterectomy due
o Start low – moderate statin when all: o Heart disease
to cervical cancer
▪ Age 40-74 o Cancer
o Stop screening at age 65
▪ CVD risk factor ▪ Men (lung,
o Risk factors:
▪ ASCVD > 10% prostate, colorectal)
▪ Multiple sex partners
➢ Lung Cancer ▪ Women (lung,
▪ Younger age at onset of sex
o Smoke 30 pack-years or quit in last 15 breast, colorectal)
▪ Immunosuppression and smoker
years o Chronic respiratory
➢ Colorectal Cancer
o Age 55-80 (annual screening with CT)
o Start age 50-75
▪ Colonoscopy every 10 years
OVARIAN CANCER ADOLESCENTS
▪ Flex sigmoidoscopy or CT
➢ Death rate for teen males is higher
colonography every 5 years ➢ No recommendation for routine screening
than females
▪ FOBT (3 consecutive stool ➢ In postmenopausal women with palpable ovary
o Accidents (MVC most
samples) annually o Intravaginal ultrasound and CA-125
common)
▪ New Cologuard ➢ Strongest risk factor is BRCA1 or BRCA2
o Suicide
o Risk Factors ➢ Other risk factors include age, obesity, Clomid
o Homicide
▪ Familial polyposis use or endometriosis
▪ First degree relative w/ colon CA ➢ Prostate/testicular cancer screening not
▪ Crohn’s (ulcerative colitis) recommended

Les avantages d'acheter des résumés chez Stuvia:

Qualité garantie par les avis des clients

Qualité garantie par les avis des clients

Les clients de Stuvia ont évalués plus de 700 000 résumés. C'est comme ça que vous savez que vous achetez les meilleurs documents.

L’achat facile et rapide

L’achat facile et rapide

Vous pouvez payer rapidement avec iDeal, carte de crédit ou Stuvia-crédit pour les résumés. Il n'y a pas d'adhésion nécessaire.

Focus sur l’essentiel

Focus sur l’essentiel

Vos camarades écrivent eux-mêmes les notes d’étude, c’est pourquoi les documents sont toujours fiables et à jour. Cela garantit que vous arrivez rapidement au coeur du matériel.

Foire aux questions

Qu'est-ce que j'obtiens en achetant ce document ?

Vous obtenez un PDF, disponible immédiatement après votre achat. Le document acheté est accessible à tout moment, n'importe où et indéfiniment via votre profil.

Garantie de remboursement : comment ça marche ?

Notre garantie de satisfaction garantit que vous trouverez toujours un document d'étude qui vous convient. Vous remplissez un formulaire et notre équipe du service client s'occupe du reste.

Auprès de qui est-ce que j'achète ce résumé ?

Stuvia est une place de marché. Alors, vous n'achetez donc pas ce document chez nous, mais auprès du vendeur NURSwalden. Stuvia facilite les paiements au vendeur.

Est-ce que j'aurai un abonnement?

Non, vous n'achetez ce résumé que pour $15.49. Vous n'êtes lié à rien après votre achat.

Peut-on faire confiance à Stuvia ?

4.6 étoiles sur Google & Trustpilot (+1000 avis)

65040 résumés ont été vendus ces 30 derniers jours

Fondée en 2010, la référence pour acheter des résumés depuis déjà 15 ans

Commencez à vendre!

Récemment vu par vous


$15.49
  • (0)
Ajouter au panier
Ajouté